Explicyte offers to perform an ADCC assay based on the full-time course monitoring of both cell proliferation and death of tumor cells, in the presence of immune cells and of candidate antibodies targeting specific tumor antigens. Our kinetic and quantitative cell-based assay allows thus the dynamic assessment and evaluation of the efficacy of test antibodies in eliciting ADCC and directing killing activity towards target tumor cells.
Antibody dependent Cell Cytotoxicity (ADCC) assessment
Explicyte offers to perform an ADCC assay based on the full-time course monitoring of both cell proliferation and death of tumor cells, in the presence of immune cells and of candidate antibodies targeting specific tumor antigens. Our kinetic and quantitative cell-based assay allows thus the dynamic assessment and evaluation of the efficacy of test antibodies in eliciting ADCC and directing killing activity towards target tumor cells.